- World rank, all time
- #34,402 of 34,923
- Rank in United States
- #7,223 of 7,310
- Research works
- 140 ▼ 14% vs 2018-21
- Citations
- 7k 50.1 per fractional work
- Top-10% rate
- 10.4% all institutions 10.0%
- vs its own fields
- 1.07× 1.00× is exactly expected
- Open access
- 40% world 40%
- International
- 15% world 18%
Which fields of science does Xencor (United States) work in?
In 2022-now, 58% of research at Xencor (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (58%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (8%). It does 2.0× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 10 fields, with their numbers
- Health Sciences1558.2%
- Medicine1558.2%
- Life Sciences832.9%
- Physical Sciences14.8%
- Computer Science13.4%
- Mathematics00.7%
- Chemistry00.7%
- Social Sciences14.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 23.6×. Every wedge is a field page.
All 10 fields, with their numbers
- Immunology and Microbiology23.63×6 works
- Medicine3.03×15 works
- Biochemistry, Genetics and Molecular Biology1.49×2 works
- Pharmacology, Toxicology and Pharmaceutics1.45×0 works
- Arts and Humanities1.35×1 works
- Mathematics0.61×0 works
- Computer Science0.44×1 works
- Chemistry0.42×0 works
- Neuroscience0.40×0 works
- Economics, Econometrics and Finance0.08×0 works
Who are the top researchers at Xencor (United States)?
Ranked on the quality score, Sher Karki, Greg A. Lazar and Omid Vafa lead among researchers whose main affiliation is Xencor (United States).
- 1
Sher Karki
United States · #128,014 worldwide 6.8k citations · 141 works
- 2
Greg A. Lazar
United States · #340,361 worldwide 5k citations · 87 works
- 3
Omid Vafa
United States · #364,246 worldwide 4.4k citations · 35 works
- 4
David E. Szymkowski
United States · #388,636 worldwide 4.6k citations · 93 works
- 5
John R. Desjarlais
United States · #409,450 worldwide 6k citations · 187 works
- 6
David F. Carmichael
United States · #616,817 worldwide 3.2k citations · 27 works
- 7
Michael Hedvat
United States · #771,322 worldwide 2k citations · 51 works
- 8
Bassil I. Dahiyat
United States · #886,236 worldwide 4k citations · 23 works
- 9
Rumana Rashid
United States · #891,808 worldwide 2.8k citations · 146 works
- 10
Umesh S. Muchhal
United States · #905,707 worldwide 2.6k citations · 108 works
Which keywords describe research at Xencor (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Lymphoma, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.
- Immunity
- Dendritic Cells
- Innate Immunity
- Natural Killer Cells
- Therapeutic Antibodies
- Monoclonal Antibodies
- Chimeric Antigen Receptor
- Tumor Regression
- Immunotherapy
- Cancer Immunotherapy
- Lymphoma
- CAR T Cells
- Glycosylation
- Fc Receptors
- NK Cell Recognition
- Tumor Microenvironment
- Antigen Presentation
- Immune Checkpoint Blockade
- PD-1 and PD-L1
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer Immunotherapy7▲ 177×3 topics
- Immunotherapy5▲ 29×5 topics
- Lymphoma5▲ 125×2 topics
- Tumor Regression5▲ 177×2 topics
- CAR T Cells5▲ 253×1 topic
- Chimeric Antigen Receptor5▲ 253×1 topic
- Glycosylation4▲ 142×2 topics
- Monoclonal Antibodies4▲ 166×2 topics
- Fc Receptors4▲ 260×1 topic
- Therapeutic Antibodies4▲ 204×1 topic
- NK Cell Recognition3▲ 165×1 topic
- Natural Killer Cells3▲ 165×1 topic
- Tumor Microenvironment2▲ 20×3 topics
- Innate Immunity2▲ 27×2 topics
- Antigen Presentation2▲ 89×1 topic
- Dendritic Cells2▲ 91×1 topic
- Immune Checkpoint Blockade2▲ 70×1 topic
- Immunity2▲ 20×2 topics
- PD-1 and PD-L12▲ 70×1 topic
Which research topics does Xencor (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 3 Immune Cell Function and Interaction Immunology 3 works
- 4 Immunotherapy and Immune Responses Immunology 2 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 6 Inflammatory Bowel Disease Genetics 0 works
- 7 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
- 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 10 T-cell and B-cell Immunology Immunology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Xencor (United States)'s research output changed?
Output in 2022-2025 was 14% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Xencor (United States) as a percentage of every work published that year, 0.00011% in 2024.
Fractional works of Xencor (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Monrovia
- Children's Oncology Group
- Tanner Research (United States)
- ChromoLogic (United States)
- California Library Association
- GeoMechanics Technologies (United States)
- AeroVironment (United States)
- Photon Spot (United States)
- Oak Crest Institute of Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Xencor (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
